Medical News

RSS

Citracal Calcium plus Heart Health helps support bone and heart health in women

Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.

6 Nov 2009

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

School-based physical education plays a key role in curbing obesity and improving fitness among adolescents from low-income communities, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.

6 Nov 2009

New advance in healthcare collaboration between CII and USIBC announced

The Confederation of Indian Industry and the U.S.-India Business Council today announced a major new advance in healthcare collaboration, partnering under the banner of the USIBC-led “Coalition for Healthy India”.

6 Nov 2009

Autism Consortium holds its fourth annual symposium to update on autism

The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.

6 Nov 2009

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

According to a Panel Intelligence survey of 50 primary care physicians, there are significant concerns about the H1N1 virus not just in terms of disease prevalence and vaccine shortages, but also in that 38% of the physicians surveyed (PCPs, pediatricians, and gerontologists) are "very concerned" about the virus evolving into a more serious strain and another 52% have moderate concerns about such a development.

6 Nov 2009

Patent covering the approved administration of Kuvan with food issued

BioMarin Pharmaceutical Inc. announced today that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food for the treatment of phenylketonuria (PKU). The patent expires in 2024.

6 Nov 2009

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

The Alliance Québécoise du Psoriasis (Quebec psoriasis alliance) would like to give its members and other psoriasis sufferers information concerning the massive H1N1 vaccination campaign.

6 Nov 2009

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility.

6 Nov 2009

James Capretta's column: The president should be opposing the house bill

In his latest column, James Capretta writes: "When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process.

6 Nov 2009

ATS issues official statement outlining its position on research, training, education, patient care and advocacy

The ATS has issued an official statement that outlines the Society's position on research, training, education, patient care and advocacy. The statement, which appears in the November 15 issue of the American Journal of Respiratory and Critical Care Medicine, also makes specific recommendations on how elements of the organization can make these policies a part of new and ongoing projects.

6 Nov 2009

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.

6 Nov 2009

Sirius Genomics signs its first Contribution Agreement with NRC-IRAP

Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). This research funding will be used to study genomic correlations in severe sepsis patients.

6 Nov 2009

CABG completed "off-pump" has no advantages in patient outcomes: Study

A study of 2,203 cardiac surgery patients from Veterans Affairs (VA) medical centers nationwide revealed that coronary-artery bypass grafting (CABG) completed "off-pump," meaning without a heart-lung machine, had no advantages in patient outcomes compared to the traditional "on-pump" procedure.

6 Nov 2009

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Varian, Inc. announced today the release of the 325-MS triple-quadrupole LC/MS (liquid chromatograph/mass spectrometer) for the efficient detection and identification of chemical compounds in high-throughput laboratories performing environmental, food safety, and toxicology analyses.

6 Nov 2009

Arthur H. Rubenstein to receive the Abraham Flexner Award

Arthur H. Rubenstein, MBBCh, Executive Vice President of the University of Pennsylvania for the Health System, and Dean, School of Medicine, will receive the Abraham Flexner Award for Distinguished Service to Medical Education from the Association of American Medical Colleges (AAMC).

6 Nov 2009

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.

6 Nov 2009

Scientists receive $3 million from NIH to uncover how plants make medicinal compounds

Scientists at Michigan State University are receiving nearly $3 million from the National Institutes of Health to uncover how several popular plants make medicinal compounds.

6 Nov 2009

Climate change is the biggest health threat to children in the 21st century, says new report

Climate change is the biggest health threat to children in the 21st century and represents an immediate global emergency, according to a new report, "Feeling the Heat," released today by Save the Children, at the Barcelona United Nations Climate Change talks.

6 Nov 2009

Successful leukemia treatment with a radiolabeled antibody followed by stem cell transplant

For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

6 Nov 2009

SAVI 6-1Mini applicator is the only brachytherapy solution for patients with small breasts, says study

The SAVI™ 6-1Mini breast brachytherapy applicator is the only brachytherapy solution for patients with small breasts, hard-to-reach lumpectomy cavities, or cavities close to the skin surface, according to a new study.

6 Nov 2009

Medical News

Citracal Calcium plus Heart Health helps support bone and heart health in women

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

New advance in healthcare collaboration between CII and USIBC announced

Autism Consortium holds its fourth annual symposium to update on autism

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

Patent covering the approved administration of Kuvan with food issued

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

James Capretta's column: The president should be opposing the house bill

ATS issues official statement outlining its position on research, training, education, patient care and advocacy

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

Sirius Genomics signs its first Contribution Agreement with NRC-IRAP

CABG completed "off-pump" has no advantages in patient outcomes: Study

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Arthur H. Rubenstein to receive the Abraham Flexner Award

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Scientists receive $3 million from NIH to uncover how plants make medicinal compounds

Climate change is the biggest health threat to children in the 21st century, says new report

Successful leukemia treatment with a radiolabeled antibody followed by stem cell transplant

SAVI 6-1Mini applicator is the only brachytherapy solution for patients with small breasts, says study

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News